A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin

British Journal of Pharmacology

Volumn 168, Issue 4, 2013, Pages 903-919

  Teshigawara, Kiyoshi ^a   Kuboyama, Tomoharu ^a   Shigyo, Michiko ^a   Nagata, Aiko ^a   Sugimoto, Kenji ^a   Matsuya, Yuji ^a   Tohda, Chihiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

5 HT fibre; axonal growth; Denosomin; reactive astrocyte; spinal cord injury; vimentin

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS; CHONDROITIN SULFATE; DENOSOMIN; SEROTONIN; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL COUNT; CELL DEATH; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; CONTUSION; DRUG MECHANISM; EMBRYO; FACILITATION; GROWTH INHIBITION; HINDLIMB; IMMUNOHISTOCHEMISTRY; MALE; MOTOR DYSFUNCTION; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SCAR; SPINAL CORD INJURY; STRUCTURE ACTIVITY RELATION; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ASTROCYTES; AXONS; CICATRIX; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR STRUCTURE; MOTOR ACTIVITY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; SPINAL CORD REGENERATION; VIMENTIN;

EID: 84872948504     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02211.x     Document Type: Article

References (50)

1. Atta-ur-Rahman, Jamal SA, Choudhary MI, (1992). Two new withanolides from Withania somnifera. Heterocycles 34: 689-698.
2. Aubert I, Ridet JL, Gage FH, (1995). Regeneration in the adult mammalian CNS: guided by development. Curr Opin Neurobiol 5: 625-635.
3. Bareyre FM, Schwab ME, (2003). Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci 26: 555-563.
4. Barrett CP, Guth L, Donati EJ, Krikorian JG, (1981). Astroglial reaction in the gray matter lumbar segments after midthoracic transection of the adult rat spinal cord. Exp Neurol 73: 365-377.
5. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG, (2006). Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23: 635-659.
6. Bignami A, Dahl D, (1974). Astrocyte-specific protein and neuroglial differentiation. An immunofluorescence study with antibodies to the glial fibrillary acidic protein. J Comp Neurol 53: 27-38.
7. Busch SA, Horn KP, Cuascut FX, Hawthorne AL, Bai L, Miller RH, et al. (2010). Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J Neurosci 30: 255-265.
8. Cordero-Llana O, Scott SA, Maslen SL, Anderson JM, Boyle J, Chowhdury RR, et al. (2011). Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells. Cell Death Differ 18: 907-913.
9. David S, Aguayo AJ, (1981). Axonal elongation into peripheral nervous system 'bridges' after central nervous system injury in adult rats. Science 214: 931-933.
10. Davies SJ, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J, (1997). Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390: 680-683.
11. Desclaux M, Teigell M, Amar L, Vogel R, Gimenez Y Ribotta M, Privat A, et al. (2009). A novel and efficient gene transfer strategy reduces glial reactivity and improves neuronal survival and axonal growth in vitro. PLoS ONE 4: e6227.
12. Eng LF, (1985). Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8: 203-214.
13. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV, (2004). Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24: 2143-2155.
14. Goldshmit Y, Bourne J, (2010). Upregulation of EphA4 on astrocytes potentially mediates astrocytic gliosis after cortical lesion in the marmoset monkey. J Neurotrauma 27: 1321-1332.
15. Goldshmit Y, Galea MP, Wise G, Bartlett PF, Turnley AM, (2004). Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 24: 100064-100073.
16. Greco TM, Seeholzer SH, Mak A, Spruce L, Ischiropoulos H, (2010). Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion. J Proteome Res 9: 2764-2774.
17. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, et al. (2008). STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28: 7231-7243.
18. Hoock TC, Newcomb PM, Herman IM, (1991). β actin and its mRNA are localized at the plasma membrane and the regions of moving cytoplasm during the cellular response to injury. J Cell Biol 112: 653-664.
19. Hsu JY, Xu XM, (2005). Early profiles of axonal growth and astroglial response after spinal cord hemisection and implantation of Schwann cell-seeded guidance channels in adult rats. J Neurosci Res 82: 472-483.
20. Huet D, Bagot M, Loyaux D, Capdevielle J, Conraux L, Ferrara P, et al. (2006). SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells. J Immunol 176: 652-659.
21. Jacobs BL, Martín-Cora FJ, Fornal CA, (2002). Activity of medullary serotonergic neurons in freely moving animals. Brain Res Rev 40: 45-52.
22. Jones LL, Margolis RU, Tuszynski MH, (2003). The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 182: 399-411.
23. Joosten EA, Gribnau AA, (1989). Astrocytes and guidance of outgrowing corticospinal tract axons in the rat. An immunocytochemical study using anti-vimentin and anti-glial fibrillary acidic protein. Neuroscience 31: 439-452.
24. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
25. Krenz NR, Weaver LC, (2000). Nerve growth factor in glia and inflammatory cells of the injured rat spinal cord. J Neurochem 74: 730-739.
26. Kuboyama T, Tohda C, Komatsu K, (2005). Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 144: 961-971.
27. Kuboyama T, Tohda C, Komatsu K, (2006). Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration. Eur J Neurosci 23: 1417-1426.
28. McCarthy KD, de Vellis J, (1980). Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
29. McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
30. McKeon RJ, Schreiber RC, Rudge JS, Silver J, (1991). Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci 11: 3398-3411.
31. Matsuya Y, Yamakawa Y, Tohda C, Teshigawara K, Yamada M, Nemoto H, (2009). Synthesis of sominone and its derivatives based on an RCM strategy: discovery of a novel anti-Alzheimer's disease medicine candidate 'denosomin'. Org Lett 11: 3970-3973.
32. Menet V, Giménez y Ribotta M, Chauvet N, Drian MJ, Lannoy J, Colucci-Guyon E, et al. (2001). Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J Neurosci 21: 6147-6158.
33. Menet V, Prieto M, Privat A, Giménez y Ribotta M, (2003). Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc Natl Acad Sci U S A 100: 8999-9004.
34. Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM, (2003). Vimentin is secreted by activated macrophages. Nat Cell Biol 5: 59-63.
35. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, et al. (2006). Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12: 829-834.
36. Olby N, (2010). The pathogenesis and treatment of acute spinal cord injuries in dogs. Vet Clin North Am Small Anim Pract 40: 791-807.
37. Ridet JL, Malhotra SK, Privat A, Gage FH, (1997). Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20: 570-577.
38. Rolls A, Shechter R, Schwartz M, (2009). The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10: 235-241.
39. Rowland JW, Hawryluk GWJ, Kwon B, Fehlings MG, (2008). Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 25: E2.
40. Ryu H, Jeon GS, Cashman NR, Kowall NW, Lee J, (2011). Differential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS. Lab Invest 91: 342-352.
41. Silver J, Miller JH, (2004). Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146-156.
42. Syková E, Svoboda J, Simonová Z, Jendelová P, (1992). Role of astrocytes in ionic and volume homeostasis in spinal cord during development and injury. Prog Brain Res 94: 47-56.
43. Tohda C, Joyashiki E, (2009). Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET. Br J Pharmacol 157: 1427-1440.
44. Tohda C, Kuboyama T, (2011). Current and future therapeutic strategies for functional repair of spinal cord injury. Pharmacol Ther 132: 57-71.
45. Tom VJ, Steinmetz MP, Miller JH, Doller CM, Silver J, (2004). Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J Neurosci 24: 6531-6539.
46. Toyooka T, Nawashiro H, Shinomiya N, Shima K, (2011). Down-regulation of glial fibrillary acidic protein and vimentin by RNA interference improves acute urinary dysfunction associated with spinal cord injury in rats. J Neurotrauma 28: 607-618.
47. White RE, Rao M, Gensel JC, McTigue DM, Kaspar BK, Jakeman LB, (2011). Transforming growth gactor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury. J Neurosci 31: 15173-15187.
48. Xia Y, Zhao T, Li J, Li L, Hu R, Hu S, et al. (2008). Antisense vimentin cDNA combined with chondroitinase ABC reduces glial scar and cystic cavity formation following spinal cord injury in rats. Biochem Biophys Res Commun 377: 562-566.
49. Xu B, deWaal RM, Mor-Vaknin N, Hibbard C, Markovitz DM, Kahn ML, (2004). The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature. Mol Cell Biol 24: 9198-9206.
50. Yiu G, He Z, (2006). Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 7: 617-627.